EUVIMEDEUVIMED entdecken
Übersichtsarbeit

La malattia di Kawasaki: l’aggiornamento delle linee guida dell’American Heart Association. Quello che i cardiologi dell’adulto devono sapere

Giuseppe Calcaterra, Lilia Oreto, Marco Perrone, Massimo Chessa, Francesco Bianco, Nunzia Borrelli, Benedetta Leonardi, Sara Moscatelli, Paolo Ciliberti, Jolanda Sabatino, Paolo Guccione, Francesco Martino und 3 weitere

Giornale Italiano di Cardiologia · 01.07.2026 · 27 (7)

DOI: 10.1714/4722.47387 ↗

Kurz gefasst

Übersichtsarbeit in der Zeitschrift Giornale Italiano di Cardiologia, erschienen am 01.07.2026. Verfasst von Giuseppe Calcaterra und 14 weiteren Autor:innen. Beteiligte Einrichtung: Università degli Studi, Palermo. Hauptthemen laut MEDLINE: Mucocutaneous Lymph Node Syndrome.

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

The recent document from the American Heart Association updates the guidelines on the diagnosis and management of Kawasaki disease (KD), a severe acute systemic inflammatory and febrile illness with mucocutaneous manifestations and lymph node involvement primarily affecting children under 5 years of age. Coronary artery involvement, with dilation and aneurysms in approximately 25% of patients, and cardiovascular system involvement make KD the most common systemic vasculitides and the leading cause of acquired heart disease in pre-school children living in developed countries. Classic KD is diagnosed based on established clinical and laboratory criteria, which exclude other similar conditions. The etiology and pathogenesis of KD remain unknown, with the disease affecting genetically susceptible children through an immune-mediated mechanism. The leading theory is that an unidentified trigger initiates a multi-organ inflammatory pathological cascade, sometimes resulting in incomplete or atypical forms in younger patients. For this reason, the American guidelines review KD diagnostic criteria, cardiac imaging techniques (echocardiography, coronary computed tomography, magnetic resonance imaging), specific therapies (intravenous immunoglobulin, aspirin, and additional treatments for resistant cases), management of myocardial infarctions, and the transition of care from pediatric to adult age. This review article also highlights future research areas, the role of inflammation, the development of differential diagnostic algorithms for multisystem inflammatory syndrome in children associated with SARS-CoV-2 infection, and the use of new oral anticoagulants. Lastly, the most recent data on the long-term course of the disease and the regression of coronary aneurysms are revisited.

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

Mucocutaneous Lymph Node SyndromeAdultChildChild, PreschoolHumansAmerican Heart AssociationCardiologistsDiagnosis, DifferentialImmunoglobulins, IntravenousPractice Guidelines as TopicUnited States

Substanzen

Immunoglobulins, Intravenous

Autor:innen und Institutionen

  • Università degli Studi, Palermo.
  • Cardiologia Pediatrica, Dipartimento di Medicina Clinica e Sperimentale, Università degli Studi, Messina.
  • Divisione di Cardiologia e CardioLab, Dipartimento di Scienze Cliniche e Medicina Traslazionale, Università degli Studi "Tor Vergata", Roma - Ospedale Pediatrico e IRCCS Bambino Gesù, Roma.
  • Centro di Cardiologia Pediatrica e Cardiopatie Congenite dell'Adulto, IRCCS Policlinico San Donato, San Donato Milanese (MI) e Università Vita-Salute San Raffaele, Milano.
  • Cardiologia e Cardiochirurgia Pediatrica e Congenita, Azienda Ospedaliero-Universitaria delle Marche, Ospedali Riuniti di Ancona, Ancona.
  • U.O.C. Cardiopatie Congenite dell'Adulto ed Aritmie Congenite e Familiari, Ospedale Monaldi, Napoli.

Zitieren

APA

Calcaterra, G., Oreto, L., Perrone, M., Chessa, M., Bianco, F., Borrelli, N., Leonardi, B., Moscatelli, S., Ciliberti, P., Sabatino, J., Guccione, P., Martino, F., Thiene, G., Di Salvo, G., & Bassareo, P. P. (2026). La malattia di Kawasaki: l’aggiornamento delle linee guida dell’American Heart Association. Quello che i cardiologi dell’adulto devono sapere. Giornale Italiano di Cardiologia, 27(7). https://doi.org/10.1714/4722.47387

Vancouver

Calcaterra G, Oreto L, Perrone M, Chessa M, Bianco F, Borrelli N, et al. La malattia di Kawasaki: l’aggiornamento delle linee guida dell’American Heart Association. Quello che i cardiologi dell’adulto devono sapere. Giornale Italiano di Cardiologia. 2026;27(7). doi:10.1714/4722.47387

BibTeX
@article{Calcaterra2026,
  author = {Calcaterra, Giuseppe and Oreto, Lilia and Perrone, Marco and Chessa, Massimo and Bianco, Francesco and Borrelli, Nunzia and Leonardi, Benedetta and Moscatelli, Sara and Ciliberti, Paolo and Sabatino, Jolanda and Guccione, Paolo and Martino, Francesco and Thiene, Gaetano and Di Salvo, Giovanni and Bassareo, Pier Paolo},
  title = {La malattia di Kawasaki: l’aggiornamento delle linee guida dell’American Heart Association. Quello che i cardiologi dell’adulto devono sapere},
  journal = {Giornale Italiano di Cardiologia},
  year = {2026},
  volume = {27},
  number = {7},
  doi = {10.1714/4722.47387}
}
Kostenlos starten →